Klausner Urges Emphasis On Research, Warns Against Shift To Health Programs.
Gregory Reaman Elected Chairman, C.O.G.; NCI Seeks Nominations For Consumer Group. “We Need A Long-Term Commitment” To Discovery.
First NCI Director To Resign Due To Presidential Election?
EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.
Perot Systems To Provide IT Support For US Oncology Enterprise Applications.
Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.
Firm Wins Patent For Method, Apparatus For Cryoablation.
Trending Stories
- A farewell post by an unidentified NCI employee triggers an accusation of “undermining the Trump administration”
- The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- Unlocking the future of precision medicine:
The untapped power of RNA - RFK Jr. floats the idea of barring government scientists from publishing in leading medical journals due to “corruption”
- Biden’s diagnosis is unfortunate but—statistically—not surprising
Of the 384 men serving in Congress, 48 are likely to be diagnosed with prostate cancer in their lifetime - Surviving cancer is often not a patient’s most challenging battle